Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Kyowa Hakko Kirin initiated phase III trial of bardoxolone methyl for diabetic kidney disease

June 4, 2018

Phase II study of MGL-3196 in NASH achieves liver biopsy endpoints at 36 weeks

June 1, 2018

Researchers from U.S. patent 5-HT1F receptor agonists

May 31, 2018

Atox initiates phase II trial of reltecimod in acute kidney injury

May 30, 2018

CLCF1 biomarker may help diagnose delayed graft function in kidney transplantation

May 25, 2018

Novo Nordisk licenses EPGN-696 from Epigen

May 25, 2018

VFMCRP and Cara sign development and commercialization agreement for CR-845

May 23, 2018

FDA approves Lokelma for hyperkalemia

May 22, 2018

Bayer patents new vasopressin V1A and V2 receptor antagonists

May 17, 2018

Dimerix announces plans for phase II trials with DMX-200 in chronic kidney disease

May 16, 2018

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...